Howard Burris
MD
President and CEO
👥Biography 个人简介
Howard Burris at Sarah Cannon has been one of the most experienced Phase I oncology clinical trialists, contributing to first-in-human studies of numerous ADCs, targeted therapies, and immunotherapy agents. His leadership in early-phase clinical oncology trials at one of the most active Phase I programs globally has been important for the clinical development of many now-approved cancer therapies.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-03-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Howard Burris 的研究动态
Follow Howard Burris's research updates
留下邮箱，当我们发布与 Howard Burris（Sarah Cannon Research Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment